Allergan, Inc. (AGN) · page 80 of 110
The slide details three specific conservative assumptions regarding life-cycle management, post-patent revenue, and cost variability.
Activist deck · appendix_methodology · summarize · sparse density
Slide locked Sign in to view
Slide schematic 4/4
callout 1/1 list 1/1 title 2/2
Components 4
primary bullet headline subtitle
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.